You are here

  • Home
  • Archive
  • Volume 71, Issue 6
  • Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities

 

Online download statistics by month:

Online download statistics by month: October 2021 to September 2024

AbstractFullPdf
Oct 20217125522
Nov 202110943312
Dec 2021483235
Jan 2022250154
Feb 2022240146
Mar 2022197202
Apr 2022242135
May 20227744120
Jun 20224283213
Jul 20222252313
Aug 202213662
Sep 2022110111
Oct 2022114130
Nov 20227151
Dec 202210580
Jan 20237272
Feb 202310611
Mar 20236942
Apr 20231600
May 20234621
Jun 20234211
Jul 20234211
Aug 20232420
Sep 20233921
Oct 20234421
Nov 20233742
Dec 20237067
Jan 20243100
Feb 20244765
Mar 20244210
Apr 20244443
May 20247732
Jun 20243600
Jul 20244601
Aug 20243600
Sep 20246155
Total6208363141